Bank of New York Mellon Corp purchased a new position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 23,151 shares of the company's stock, valued at approximately $3,956,000. Bank of New York Mellon Corp owned about 0.34% of Nutex Health as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. GSA Capital Partners LLP bought a new position in Nutex Health during the 2nd quarter worth approximately $307,000. Plan Group Financial LLC purchased a new position in Nutex Health in the 2nd quarter worth approximately $282,000. Bank of America Corp DE lifted its position in Nutex Health by 52.3% in the first quarter. Bank of America Corp DE now owns 9,027 shares of the company's stock valued at $858,000 after purchasing an additional 3,101 shares during the last quarter. Smith Group Asset Management LLC bought a new stake in Nutex Health in the first quarter valued at approximately $1,244,000. Finally, EverSource Wealth Advisors LLC bought a new stake in Nutex Health in the first quarter valued at approximately $83,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research analysts have recently issued reports on NUTX shares. Zacks Research upgraded shares of Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Monday, August 24th. Weiss Ratings upgraded shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, July 28th. Wall Street Zen cut shares of Nutex Health from a "buy" rating to a "hold" rating in a research report on Saturday. B Riley reissued a "buy" rating on shares of Nutex Health in a report on Friday. Finally, B. Riley Financial boosted their price objective on shares of Nutex Health from $290.00 to $325.00 and gave the company a "buy" rating in a research report on Friday. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average price target of $317.50.
Get Our Latest Stock Analysis on Nutex Health
Nutex Health Stock Down 2.2%
Shares of Nutex Health stock opened at $193.24 on Friday. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The company's fifty day simple moving average is $175.59 and its two-hundred day simple moving average is $136.75. The company has a market cap of $1.32 billion, a P/E ratio of 7.59 and a beta of 0.28. Nutex Health Inc. has a 12-month low of $80.53 and a 12-month high of $204.00.
Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 EPS for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million.
About Nutex Health
(
Free Report)
Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.